Suzan van de Steeg

Suzan van de Steeg

Suzan is a PhD Candidate in Early Health Technology Assessment for the Holland Hybrid Heart at Erasmus Medical Centre. Previously she graduated from the European Master in Health Economics and Management with a specialization in Economic Evaluation.

Her research focuses on developing a health economic model to simulate societal-level outcomes, such as costs and effects, of the Holland Hybrid Heart. This model will compare the Holland Hybrid Heart to current treatment alternatives, enabling us to investigate the sensitivity of cost-effectiveness to changes in its characteristics and the maximum costs in order to be cost-effective.

While good health is invaluable, the funds available for healthcare are limited, and difficult decisions must be made about which treatments to reimburse. Therefore, working towards and demonstrating that the Holland Hybrid Heart will deliver value for money is an important step towards bringing this innovation to patients.

Holland Hybrid Heart

seeks to create a biocompatible artificial heart using soft robotics and tissue engineering. This innovative heart aims to improve life expectancy and quality of life for heart failure patients while reducing reliance on scarce donor organs.

Stay connected on LinkedIn. For inquiries, contact us via email.

Holland Hybrid Heart

seeks to create a biocompatible artificial heart using soft robotics and tissue engineering. This innovative heart aims to improve life expectancy and quality of life for heart failure patients while reducing reliance on scarce donor organs.

Stay connected on LinkedIn. For inquiries, contact us via email.

Holland Hybrid Heart

seeks to create a biocompatible artificial heart using soft robotics and tissue engineering. This innovative heart aims to improve life expectancy and quality of life for heart failure patients while reducing reliance on scarce donor organs.

Stay connected on LinkedIn. For inquiries, contact us via email.

Holland Hybrid Heart

seeks to create a biocompatible artificial heart using soft robotics and tissue engineering. This innovative heart aims to improve life expectancy and quality of life for heart failure patients while reducing reliance on scarce donor organs.

Stay connected on LinkedIn. For inquiries, contact us via email.